The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Dec 2020)
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
Fabrizio Vincenzi,
Silvia Pasquini,
Enrica Battistello,
Stefania Merighi,
Stefania Gessi,
Pier Andrea Borea,
Katia Varani
Affiliations
Fabrizio Vincenzi
Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy
Silvia Pasquini
Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy
Enrica Battistello
Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy
Stefania Merighi
Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy
Stefania Gessi
Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy
Pier Andrea Borea
University of Ferrara, Ferrara, Italy
Katia Varani
Department of Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy
DOI
https://doi.org/10.3389/fphar.2020.625134
Journal volume & issue
Vol. 11
Abstract
Read online
No abstracts available.
Keywords
adenosine
positive allosteric modulators
partial agonists
A1 adenosine receptors
clinical trials
WeChat QR code
Close